Gabapentin Under Scrutiny: 2025 Data Challenged Safety Profile

(MedPage Today) — In January 2025, we reported that some adverse events associated with gabapentin (Neurontin) may have been overestimated. Since then, new risks related to gabapentin emerged and prescribing continued to rise. Here’s what we learned…